BACKGROUND: A(H5N1) and A(H9N2) avian influenza viruses are enzootic in Egyptian poultry, and most A(H5N1) human cases since 2009 have occurred in Egypt. Our understanding of the epidemiology of avian viruses in humans remains limited. Questions about the frequency of infection, the proportion of infections that are mild or subclinical, and the case-fatality rate remain largely unanswered. METHODS: We conducted a 3-year, prospective, controlled, seroepidemiological study that enrolled 750 poultry-exposed and 250 unexposed individuals in Egypt. RESULTS: At baseline, the seroprevalence of anti-A(H5N1) antibodies (titer, ≥80) among exposed individuals was 2% significantly higher than that among the controls (0%). Having chronic lung disease was a significant risk factor for infection. Antibodies against A(H9N2) were not detected at baseline when A(H9N2) was not circulating in poultry. At follow-up, A(H9N2) was detected in poultry, and consequently, the seroprevalence among exposed humans was between 5.6% and 7.5%. Vaccination of poultry, older age, and exposure to ducks were risk factors for A(H9N2) infection. CONCLUSIONS: Results of this study indicate that the number of humans infected with avian influenza viruses is much larger than the number of reported confirmed cases. In an area where these viruses are enzootic in the poultry, human exposure to and infection with avian influenza becomes more common.
BACKGROUND: A(H5N1) and A(H9N2) avian influenza viruses are enzootic in Egyptian poultry, and most A(H5N1) human cases since 2009 have occurred in Egypt. Our understanding of the epidemiology of avian viruses in humans remains limited. Questions about the frequency of infection, the proportion of infections that are mild or subclinical, and the case-fatality rate remain largely unanswered. METHODS: We conducted a 3-year, prospective, controlled, seroepidemiological study that enrolled 750 poultry-exposed and 250 unexposed individuals in Egypt. RESULTS: At baseline, the seroprevalence of anti-A(H5N1) antibodies (titer, ≥80) among exposed individuals was 2% significantly higher than that among the controls (0%). Having chronic lung disease was a significant risk factor for infection. Antibodies against A(H9N2) were not detected at baseline when A(H9N2) was not circulating in poultry. At follow-up, A(H9N2) was detected in poultry, and consequently, the seroprevalence among exposed humans was between 5.6% and 7.5%. Vaccination of poultry, older age, and exposure to ducks were risk factors for A(H9N2) infection. CONCLUSIONS: Results of this study indicate that the number of humans infected with avian influenza viruses is much larger than the number of reported confirmed cases. In an area where these viruses are enzootic in the poultry, human exposure to and infection with avian influenza becomes more common.
Authors: Rabeh El-Shesheny; Ahmed Kandeil; Ola Bagato; Asmaa M Maatouq; Yassmin Moatasim; Adam Rubrum; Min-Suk Song; Richard J Webby; Mohamed Ahmed Ali; Ghazi Kayali Journal: J Gen Virol Date: 2014-04-10 Impact factor: 3.891
Authors: Christopher H Clegg; Richard Roque; Neal Van Hoeven; Lucy Perrone; Susan L Baldwin; Joseph A Rininger; Richard A Bowen; Steven G Reed Journal: Proc Natl Acad Sci U S A Date: 2012-10-08 Impact factor: 11.205
Authors: Rabeh El-Shesheny; Ghazi Kayali; Ahmed Kandeil; Zhipeng Cai; Ahmed B Barakat; Hossam Ghanim; Mohamed A Ali Journal: J Gen Virol Date: 2012-09-05 Impact factor: 3.891
Authors: Ghazi Kayali; Richard J Webby; Mariette F Ducatez; Rabeh A El Shesheny; Ahmed M Kandeil; Elena A Govorkova; Ahmed Mostafa; Mohamed A Ali Journal: PLoS One Date: 2011-03-21 Impact factor: 3.240
Authors: Magdi D Saad; Lu'ay S Ahmed; Mohamed A Gamal-Eldein; Mohamed K Fouda; Fouda Khalil; Samuel L Yingst; Michael A Parker; Marshall R Montevillel Journal: Emerg Infect Dis Date: 2007-07 Impact factor: 6.883
Authors: Mary Younan; Mee Kian Poh; Emad Elassal; Todd Davis; Pierre Rivailler; Amanda L Balish; Natosha Simpson; Joyce Jones; Varough Deyde; Rosette Loughlin; Ije Perry; Larisa Gubareva; Maha A ElBadry; Shaun Truelove; Anne M Gaynor; Emad Mohareb; Magdy Amin; Claire Cornelius; Guillermo Pimentel; Kenneth Earhart; Amel Naguib; Ahmed S Abdelghani; Samir Refaey; Alexander I Klimov; Ruben O Donis; Amr Kandeel Journal: Emerg Infect Dis Date: 2013-01 Impact factor: 6.883
Authors: Ghazi Kayali; Ahmed Kandeil; Rabeh El-Shesheny; Ahmed S Kayed; Mokhtar M Gomaa; Asmaa M Maatouq; Mahmoud M Shehata; Yassmin Moatasim; Ola Bagato; Zhipeng Cai; Adam Rubrum; Mohamed A Kutkat; Pamela P McKenzie; Robert G Webster; Richard J Webby; Mohamed A Ali Journal: Emerg Infect Dis Date: 2014-04 Impact factor: 6.883
Authors: A A Hill; T Dewé; R Kosmider; S Von Dobschuetz; O Munoz; A Hanna; A Fusaro; M De Nardi; W Howard; K Stevens; L Kelly; A Havelaar; K Stärk Journal: R Soc Open Sci Date: 2015-09-09 Impact factor: 2.963
Authors: Amira S El Rifay; Mona A Elabd; Dina Abu Zeid; Mokhtar R Gomaa; Li Tang; Pamela P McKenzie; Richard J Webby; Mohamed A Ali; Ghazi Kayali Journal: JMIR Res Protoc Date: 2015-06-22